BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20182846)

  • 1. Prospective comparative study of negative oral contrast agents for magnetic resonance cholangiopancreatography.
    Morita S; Ueno E; Masukawa A; Suzuki K; Fujimura M; Hirabayashi N; Kojima S; Hirata M; Kitajima K; Kaji Y
    Jpn J Radiol; 2010 Feb; 28(2):117-22. PubMed ID: 20182846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR signal changes on hepatobiliary imaging after oral ingestion of manganese chloride tetrahydrate: preliminary examination.
    Marugami N; Takewa M; Iwaki Y; Hazeyama Y; Iwato K; Takahama J; Marugami A; Okuaki T; Kichikawa K
    Jpn J Radiol; 2013 Nov; 31(11):713-23. PubMed ID: 24068585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of pineapple juice as a negative oral contrast agent in magnetic resonance cholangiopancreatography.
    Alshehri FM
    J Clin Diagn Res; 2015 Jan; 9(1):TC13-6. PubMed ID: 25738055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of 3-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 3-dimensional turbo-spin-echo magnetic resonance cholangiopancreatography.
    Itatani R; Namimoto T; Takaoka H; Katahira K; Noda S; Toyonari N; Yamashita Y
    J Comput Assist Tomogr; 2015; 39(1):19-24. PubMed ID: 25299796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
    Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
    Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of common bile duct motion artifacts caused by inferior vena cava pulsation on magnetic resonance cholangiopancreatography.
    Morita S; Ueno E; Saito N; Suzuki K; Machida H; Fujimura M; Maruyama K; Onodera Y; Watanabe K; Suzuki T; Ohnishi T; Imura C; Mitsuhashi N
    Magn Reson Med Sci; 2008; 7(1):31-6. PubMed ID: 18460846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance cholangiopancreatography (MRCP) using new negative per-oral contrast agent based on superparamagnetic iron oxide nanoparticles for extrahepatic biliary duct visualization in liver cirrhosis.
    Polakova K; Mocikova I; Purova D; Tucek P; Novak P; Novotna K; Izak N; Bielik R; Zboril R; Miroslav H
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):512-517. PubMed ID: 27641140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of normal bile duct and pancreatic duct with MR cholangiopancreatography].
    Toda J; Ueno E; Takada Y; Okawa T
    Nihon Rinsho; 1998 Nov; 56(11):2830-5. PubMed ID: 9847605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid 3D navigator-triggered MR cholangiopancreatography with SPACE sequence at 3T: only one-third acquisition time of conventional 3D SPACE navigator-triggered MRCP.
    Sun B; Chen Z; Duan Q; Xue Y; Zheng E; He Y; Lin L; Li G; Zhang Z
    Abdom Radiol (NY); 2020 Jan; 45(1):134-140. PubMed ID: 31781898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of MR cholangiopancreatography (MRCP) images after black tea consumption.
    Ghanaati H; Rokni-Yazdi H; Jalali AH; Abahashemi F; Shakiba M; Firouznia K
    Eur Radiol; 2011 Dec; 21(12):2551-7. PubMed ID: 21818525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the Short-Echo Time Cube Sequence at 3-T Magnetic Resonance Cholangiopancreatography: Prospective Comparison With the Conventional 3-Dimensional Fast Spin-Echo Sequence.
    Itatani R; Namimoto T; Kusunoki S; Mizuguchi T; Ohtsuka S; Yamashita Y
    J Comput Assist Tomogr; 2016; 40(4):551-6. PubMed ID: 26966952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
    Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
    Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality rating of MR-cholangiopancreatography with oral application of iron oxide particles].
    Lorenzen M; Wedegärtner U; Fiehler J; Adam G
    Rofo; 2003 Jul; 175(7):936-41. PubMed ID: 12847648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Low-temperature Manganese Chloride Tetrahydrate Improves the Image Quality of Magnetic Resonance Cholangiopancreatography].
    Watanabe K; Ishimori Y; Sakurai H; Iwai Y; Miida K; Kurita K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Apr; 72(4):311-8. PubMed ID: 27097992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified breath-hold compressed-sensing 3D MR cholangiopancreatography with a small field-of-view and high resolution acquisition: Clinical feasibility in biliary and pancreatic disorders.
    Zhu L; Xue H; Sun Z; Qian T; Weiland E; Kuehn B; Asbach P; Hamm B; Jin Z
    J Magn Reson Imaging; 2018 Nov; 48(5):1389-1399. PubMed ID: 29656611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel imaging improves the image quality and duct visibility of breathhold two-dimensional thick-slab MR cholangiopancreatography.
    Lee JH; Lee SS; Kim JY; Kim IS; Byun JH; Park SH; Lee MG
    J Magn Reson Imaging; 2014 Feb; 39(2):269-75. PubMed ID: 23596083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR cholangiopancreatography (MRCP).
    Vrachliotis TG; Shirkhoda A; Bis KG; Shetty AN; Konez O; Ference JJ; Madrazo BL
    Crit Rev Diagn Imaging; 1997 Aug; 38(4):295-323. PubMed ID: 9376087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of a new sequence of magnetic resonance cholangio-pancreatography in thick cut and one shot acquisition].
    Mougenel JL; Hudziak H; Ernst O; Dupas B; Lefevre F; Barraud H; Watelet J; Cezard O; Regent D; Bigard MA
    Gastroenterol Clin Biol; 2000 Oct; 24(10):888-95. PubMed ID: 11084424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP.
    Chan JH; Tsui EY; Yuen MK; Szeto ML; Luk SH; Wong KP; Wong NO
    Abdom Imaging; 2000; 25(4):405-8. PubMed ID: 10926195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent.
    Hirohashi S; Hirohashi R; Uchida H; Kitano S; Ono W; Ohishi H; Nakanishi S
    Radiology; 1997 Apr; 203(1):281-5. PubMed ID: 9122408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.